Skip to main content
Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
19.31
0.00 (0.00%)
At close: May 23, 2025

TEVJF Revenue

Teva Pharmaceutical Industries had revenue of $3.89B in the quarter ending March 31, 2025, with 1.89% growth. This brings the company's revenue in the last twelve months to $16.62B, up 3.82% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.

Revenue (ttm)
16.62B
Revenue Growth
+3.82%
P/S Ratio
1.25
Revenue / Employee
449.08K
Employees
35,686
Market Cap
20.82B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Elite Pharmaceuticals 70.00M
Glass House Brands 215.62M
Northwest Biotherapeutics 1.47M
Silence Therapeutics 27.70M
BioStem Technologies 332.45M
Revenue Rankings

Teva Pharmaceutical Industries News

More News